Allergy Treatment - Global Strategic Business Report to 2030: Increasing Availability of OTC Allergy Medications, Advances in Biologic Therapies Propel Growth
July 26, 2024 06:23 ET
|
Research and Markets
Dublin, July 26, 2024 (GLOBE NEWSWIRE) -- The "Allergy Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Allergy...
INmune Bio Inc. Publishes Novel Biology on Natural Killer Cancer Immunotherapy INKmune™ in the Journal for ImmunoTherapy of Cancer
July 23, 2024 08:45 ET
|
INmune Bio, Inc.
Publication of detailed analysis on INKmune biology compared to cytokine stimulated cells demonstrates important anti-tumor memory like NK cell characteristics BOCA RATON, Fla., July 23, 2024 ...
Bladder Cancer Treatment Drug Market to Attain $14.24 billion by 2034, with 14.1% CAGR | Fact.MR Report
July 23, 2024 06:30 ET
|
FACT.MR
Rockville, MD., July 23, 2024 (GLOBE NEWSWIRE) -- According to a new report published by Fact.MR, the global Bladder Cancer Treatment Drug Market is estimated to reach a value of US$ 3.79 billion in...
Immatics Announces Upcoming Oral Presentation at ESMO Congress 2024
July 18, 2024 09:00 ET
|
https://immatics.com/
Houston, Texas and Tuebingen, Germany, July 18, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T...
Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform
July 18, 2024 08:00 ET
|
Calidi Biotherapeutics, Inc
SAN DIEGO, July 18, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor...
Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board
July 16, 2024 08:00 ET
|
Calidi Biotherapeutics, Inc
SAN DIEGO, July 16, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor...
CCR8 Targeted Antibody Immunotherapy Pipeline Review 2024: An Emerging, Highly Attractive Next Generation Immuno-oncology Target
July 08, 2024 04:08 ET
|
Research and Markets
Dublin, July 08, 2024 (GLOBE NEWSWIRE) -- The "CCR8-Targeted Antibody Immunotherapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. CCR8 is an emerging, highly...
Synthetic Immunology Market Report 2024 with Profiles of ADC Therapeutics, BioNTech, Camena Bioscience, CRISPR Therapeutics, Editas Medicine, Sherlock Biosciences, Synlogic Therapeutics & Synthego
July 04, 2024 07:28 ET
|
Research and Markets
Dublin, July 04, 2024 (GLOBE NEWSWIRE) -- The "Synthetic Immunology Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Synthetic Immunology Market is...
Global Food Allergy Treatment Market Size To Worth USD 13.76 Billion By 2033 | CAGR of 9.27%
June 28, 2024 22:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , June 28, 2024 (GLOBE NEWSWIRE) -- The Global Food Allergy Treatment Market Size is to Grow from USD 5.67 Billion in 2023 to USD 13.76 Billion by 2033, at a Compound Annual...
Global Immunomodulator Market Projected to Nearly Double, Reaching $477.55 Billion by 2034 - Evolution of Immunomodulatory Treatments for Cancer Creating Lucrative Opportunities for Oncology Applications
June 27, 2024 09:43 ET
|
Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Global Immunomodulator Market" report has been added to ResearchAndMarkets.com's offering.In a significant development for the healthcare industry,...